Financhill
Sell
30

GBFH Quote, Financials, Valuation and Earnings

Last price:
$35.37
Seasonality move :
10.95%
Day range:
$35.15 - $36.50
52-week range:
$27.30 - $46.00
Dividend yield:
0%
P/E ratio:
27.27x
P/S ratio:
4.88x
P/B ratio:
3.20x
Volume:
33.4K
Avg. volume:
53.8K
1-year change:
0.14%
Market cap:
$506M
Revenue:
$91.4M
EPS (TTM):
$1.29

GBFH Analysts' Consensus Rating

The 2 analysts providing 12-month price projections for GBank Financial Holdings, Inc. shares anticipate an average target of $52.50, ranging from a low estimate of $50.00 to a high estimate of $55.00. This average target implies a growth of 49.15% compared to the current stock price of $35.20.

Consensus Price Target

$52.50

Highest Price Target

$55.00

Lowest Price Target

$50.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 2 2

Hold 0 0 0

Sell 0 0 0
Consensus -- Buy Buy

GBFH Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 0.7% over the past day.

Buy
68
KOD alert for Dec 26

Kodiak Sciences, Inc. [KOD] is down 1.61% over the past day.

Buy
64
ZCSH alert for Dec 23

Grayscale Zcash Trust (ZEC) [ZCSH] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock